Biotech News

Join the Boston Biotech Meetup for Advances in Gene Therapy, an evening of networking, presentations and discussion with local scientists.

BERKELEY, Calif. - March 27, 2017 - -- Leadership, employees and stakeholders of Berkeley Lights celebrate the launch of a new brand-focused website which tells their story: the partnership of science and engineering, to transform the lives of...

IRVINE, Calif. - March 27, 2017 - -- The staggering cost of cancer treatment means only patients living in the wealthiest countries have access to the latest treatment options against cancer. Even among the most affluent countries like the US, many...

Biosceptre has published a clinical study demonstrating that its topical drug BIL010t provides a novel, safe and tolerable topical therapy for BCC in the British Journal of Dermatology (BJD)

IRVINE, Calif. - Feb. 15, 2017 - -- HOPE BIOSCIENCES, INC. announced today that Dr. Michael Adam has joined the management team to oversee Pharmaceutical and Manufacturing Operations as well as Regulatory Affairs and Quality Assurance.

SARASOTA, Fla. - Nov. 10, 2016 - -- Generis Knowledge Management Inc. announced today that a top 10 global biotechnology company has chosen CARA to replace their existing Vault system for the distribution of PSURs, EdTs and associated documents to...

Eight Student Innovators Will Present November 11, 2016 at Ocean Exchange in Savannah, GA in Georgia Southern University College of Business Sponsored Competition.

tealbook's potential for market traction and revenue growth recognized by UNPACK Boston's team of potential partners, customers and investors.

New animal facilities for rodent pharmacokinetic studies launched

Dr. Daniel Holterman is now Chief Science Officer and CLIA Lab Director at Beacon Biomedical

Biosceptre announces today that Professor Francesco Di Virgilio, an international expert on the role of P2X7 in cancer, has joined the Scientific Advisory Board alongside its existing members, Sir Gregory Winter and Professor Terence Rabbitts.

Beacon has reached some significant milestones with its BeScreened™-CRC colorectal cancer screening test having demonstrated in its initial clinical data 95% accuracy across all patient demographics. Prior to and following the meeting, management...

Singular Research Hosts SPRING SELECT "Best of the Uncovered" Investment Conference

The MedtoMarket founders are excited to announce the addition of industry veteran, Ms. Loxley A. Browne, as Senior Vice President of Communications.

AUSTIN, Texas - May 18, 2016 - -- Mystic Pharmaceuticals, Inc., a privately held, life science technology company, announced today it has received a patent from the Japanese Patent Office for its "Combination Unit Dose Dispensing Container" (Japanese...

Beacon Biomedical Inc. Appoints Industry Veteran To Lead Cancer Screening Technology Commercialization

BOTHELL, Wash. - Feb. 18, 2016 - -- A group of twelve Washington State Opportunity Scholarship (WSOS) recipients will tour local biotechnology company Helix BioMedix, Inc. as part of the scholarship's Industry Exploration event series. Occurring on...

Will receive up to $250,000 to make cancer screening easy, accurate and affordable

xRapid is a world first in mobile health, providing automatic diagnosis of malaria via an iPhone app. It is the first commercially available mobile app that has the functionality to quickly and accurately diagnose a major disease.

Join us for Special Speakers & guests: Legends and Luminaries in Finance, Technology and Media.

Join us for Special Speakers & guests: Legends and Luminaries in Finance, Technology and Media.